{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:58Z","timestamp":1790704858085,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1014646","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000}}],"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008013","name":"University of Texas Medical Branch at Galveston","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health","award":["UC7AI094660"],"award-info":[{"award-number":["UC7AI094660"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Nipah virus (NiV) and Hendra virus (HeV) are highly pathogenic paramyxoviruses that produce severe, often fatal disease in humans and animals. Zoonotic spillover of these henipaviruses from the Pteropid bat natural reservoir occurs near-annually in Southeast Asia and Oceania. Outbreaks of NiV disease frequently exceed case fatality rates of 75%, and person-to-person transmission makes controlling outbreaks in low-resource environments challenging. HeV is less transmissible between humans; however, the overall mortality rate is 57%. Approaches to human vaccine development have largely focused on NiV given the larger case burden, and immunogen selection has centered on display of the NiV attachment (G) or fusion (F) surface glycoproteins. However, experimental vaccines displaying these NiV antigens have failed to uniformly cross-protect against HeV disease in preclinical models. The HeV (G) antigen was shown to cross-protect against both HeV and NiV when delivered in a protein subunit form; however, attempts to utilize mRNA or canarypox vectors failed to achieve equivalent protection. We previously developed and evaluated a single-cycle recombinant vesicular stomatitis virus-vectored vaccine displaying the (G) glycoprotein of Nipah virus strain Bangladesh (NiV-B). This experimental vaccine (G*rVSV\u2206G-NiV-G) demonstrated ideal characteristics of rapid and durable protection against NiV-B challenge in nonhuman primates. In the present work, we show that the G*rVSV\u2206G-NiV-G vaccine cross-protects against lethal HeV challenge, with the protective response driven by a balance of both cell-mediated and humoral compartments.<\/jats:p>","DOI":"10.1371\/journal.ppat.1014646","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:41:02Z","timestamp":1790098862000},"page":"e1014646","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A single-cycle, recombinant VSV platform Nipah vaccine cross-protects against Hendra virus in nonhuman primates"],"prefix":"10.1371","volume":"22","author":[{"given":"Declan D.","family":"Pigeaud","sequence":"first","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Turcinovic","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Deer","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mack B.","family":"Harrison","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Dobias","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek N.","family":"Prasad","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla A.","family":"Fenton","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-1877","authenticated-orcid":true,"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Galveston National Laboratory"]},{"name":"University of Texas Medical Branch","place":["Galveston, Texas, United States of America"],"department":["Department of Microbiology and Immunology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"5207","key":"ppat.1014646.ref001","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.7701348","article-title":"A morbillivirus that caused fatal disease in horses and humans","volume":"268","author":"K Murray","year":"1995","journal-title":"Science"},{"issue":"9186","key":"ppat.1014646.ref002","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(99)04299-3","article-title":"Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia","volume":"354","author":"KB Chua","year":"1999","journal-title":"Lancet"},{"issue":"9186","key":"ppat.1014646.ref003","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(99)04379-2","article-title":"Outbreak of Nipah-virus infection among abattoir workers in Singapore","volume":"354","author":"NI Paton","year":"1999","journal-title":"Lancet"},{"key":"ppat.1014646.ref004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fvets.2019.00016","article-title":"Vaccine Development for Nipah Virus Infection in Pigs","volume":"6","author":"RK McLean","year":"2019","journal-title":"Front Vet Sci"},{"key":"ppat.1014646.ref005","doi-asserted-by":"crossref","first-page":"100162","DOI":"10.1016\/j.onehlt.2020.100162","article-title":"Hendra in the Hunter Valley","volume":"10","author":"KM Williamson","year":"2020","journal-title":"One Health"},{"issue":"7","key":"ppat.1014646.ref006","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/vaccines9070731","article-title":"Sero-monitoring of horses demonstrates the equivac\u00ae hev hendra virus vaccine to be highly effective in inducing neutralising antibody titres","volume":"9","author":"K Halpin","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"ppat.1014646.ref007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2990.2008.00991.x","article-title":"Human Hendra virus infection causes acute and relapsing encephalitis","volume":"35","author":"KT Wong","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"ppat.1014646.ref008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3201\/eid1602.090552","article-title":"Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008","volume":"16","author":"EG Playford","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"ppat.1014646.ref009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"AN Freiberg","year":"2010","journal-title":"J Gen Virol"},{"issue":"19","key":"ppat.1014646.ref010","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.01163-10","article-title":"A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment","volume":"84","author":"B Rockx","year":"2010","journal-title":"J Virol"},{"issue":"105","key":"ppat.1014646.ref011","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002901","article-title":"A neutralizing human monoclonal antibody protects African green monkeys from hendra virus challenge","volume":"3","author":"KN Bossart","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"ppat.1014646.ref012","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(19)30634-6","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: A first-in-human, randomised, controlled, phase 1 study","volume":"20","author":"EG Playford","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ppat.1014646.ref013","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3201\/eid1307.061128","article-title":"Person-to-person transmission of Nipah virus in a Bangladeshi community","volume":"13","author":"ES Gurley","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"ppat.1014646.ref014","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1017\/S0950268810000695","article-title":"Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007","volume":"138","author":"N Homaira","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"1","key":"ppat.1014646.ref015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid2401.161758","article-title":"Nipah virus contamination of hospital surfaces during outbreaks, Bangladesh, 2013-2014","volume":"24","author":"MZ Hassan","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"ppat.1014646.ref016","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/infdis\/jiy612","article-title":"Outbreak investigation of nipah virus disease in Kerala, India, 2018","volume":"219","author":"G Arunkumar","year":"2019","journal-title":"J Infect Dis"},{"issue":"4","key":"ppat.1014646.ref017","first-page":"553","article-title":"Nipah\/Hendra virus outbreak in Siliguri, West Bengal, India in 2001","volume":"123","author":"AK Harit","year":"2006","journal-title":"Indian J Med Res"},{"issue":"7","key":"ppat.1014646.ref018","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1086\/529147","article-title":"Clinical presentation of nipah virus infection in Bangladesh","volume":"46","author":"MJ Hossain","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ppat.1014646.ref019","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.ijregi.2024.100434","article-title":"Twenty-five years of Nipah outbreaks in Southeast Asia: A persistent threat to global health","volume":"13","author":"S Khan","year":"2024","journal-title":"IJID Reg"},{"key":"ppat.1014646.ref020","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.lansea.2024.100527","article-title":"Improving clinical care of patients in Nipah outbreaks: moving beyond \u201ccompassionate use\u201d","volume":"33","author":"MZ Hassan","year":"2025","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"242","key":"ppat.1014646.ref021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008929","article-title":"Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody","volume":"6","author":"TW Geisbert","year":"2014","journal-title":"Sci Transl Med"},{"key":"ppat.1014646.ref022","doi-asserted-by":"crossref","first-page":"30916","DOI":"10.1038\/srep30916","article-title":"Pathogenic differences between nipah virus bangladesh and malaysia strains in primates: implications for antibody therapy","volume":"6","author":"CE Mire","year":"2016","journal-title":"Sci Rep"},{"issue":"741","key":"ppat.1014646.ref023","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl2055","article-title":"Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates","volume":"16","author":"L Zeitlin","year":"2024","journal-title":"Sci Transl Med"},{"issue":"10","key":"ppat.1014646.ref024","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","article-title":"An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections","volume":"26","author":"HV Dang","year":"2019","journal-title":"Nat Struct Mol Biol"},{"issue":"24","key":"ppat.1014646.ref025","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1128\/JVI.01619-06","article-title":"Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine","volume":"80","author":"BA Mungall","year":"2006","journal-title":"J Virol"},{"issue":"31","key":"ppat.1014646.ref026","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2008.05.016","article-title":"A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats","volume":"26","author":"JA McEachern","year":"2008","journal-title":"Vaccine"},{"issue":"34","key":"ppat.1014646.ref027","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1016\/j.vaccine.2011.06.015","article-title":"A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge","volume":"29","author":"J Pallister","year":"2011","journal-title":"Vaccine"},{"key":"ppat.1014646.ref028","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1743-422X-10-237","article-title":"Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months","volume":"10","author":"JA Pallister","year":"2013","journal-title":"Virol J"},{"issue":"9","key":"ppat.1014646.ref029","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/JVI.00005-14","article-title":"A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge","volume":"88","author":"CE Mire","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014646.ref030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-021-00284-w","article-title":"A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus","volume":"6","author":"TW Geisbert","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ppat.1014646.ref031","article-title":"Evaluation of a single-dose nucleoside-modified messenger RNA vaccine encoding hendra virus-soluble glycoprotein against lethal nipah virus challenge in syrian hamsters","volume":"221","author":"MK Lo","year":"2020","journal-title":"J Infect Dis"},{"issue":"3","key":"ppat.1014646.ref032","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis699","article-title":"Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines","volume":"207","author":"A Ploquin","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"ppat.1014646.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007462","article-title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters","volume":"13","author":"N van Doremalen","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"ppat.1014646.ref034","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-10-353","article-title":"Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease","volume":"10","author":"CE Mire","year":"2013","journal-title":"Virol J"},{"issue":"3","key":"ppat.1014646.ref035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164946","article-title":"Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease","volume":"133","author":"C Woolsey","year":"2023","journal-title":"J Clin Invest"},{"issue":"12","key":"ppat.1014646.ref036","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200065119","article-title":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease","volume":"119","author":"SL Foster","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1014646.ref037","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41541-024-01036-2","article-title":"Establishing an immune correlate of protection for Nipah virus in nonhuman primates","volume":"9","author":"VH Leyva-Grado","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"4","key":"ppat.1014646.ref038","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"B Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"ppat.1014646.ref039","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","article-title":"Improved metagenomic analysis with Kraken 2","volume":"20","author":"DE Wood","year":"2019","journal-title":"Genome Biol"},{"issue":"16","key":"ppat.1014646.ref040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"22","key":"ppat.1014646.ref041","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"A Wilm","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ppat.1014646.ref042","unstructured":"Pag\u00e8s H, Aboyoun P, Gentleman R, DebRoy S. Biostrings: efficient manipulation of biological strings. 2024."},{"issue":"1","key":"ppat.1014646.ref043","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-025-01343-2","article-title":"A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challenge","volume":"11","author":"DD Pigeaud","year":"2026","journal-title":"NPJ Vaccines"},{"issue":"7","key":"ppat.1014646.ref044","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"ppat.1014646.ref045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"AM Newman","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"7","key":"ppat.1014646.ref046","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/1365-2664.14415","article-title":"Environmental variation across multiple spatial scales and temporal lags influences Hendra virus spillover","volume":"60","author":"CL Faust","year":"2023","journal-title":"J Appl Ecol"},{"issue":"146","key":"ppat.1014646.ref047","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge","volume":"4","author":"KN Bossart","year":"2012","journal-title":"Sci Transl Med"},{"issue":"10521","key":"ppat.1014646.ref048","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/S0140-6736(25)01390-X","article-title":"Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study","volume":"406","author":"Jr Frenck RW","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"ppat.1014646.ref049","article-title":"Persistent T cell immunity following nipah virus infection: evidence from Malaysian survivors","volume":"233","author":"PAS Ibrahim","year":"2026","journal-title":"J Infect Dis"},{"issue":"40","key":"ppat.1014646.ref050","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/j.vaccine.2016.08.028","article-title":"Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response","volume":"34","author":"BS Pickering","year":"2016","journal-title":"Vaccine"},{"issue":"31","key":"ppat.1014646.ref051","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh4057","article-title":"Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination","volume":"9","author":"SR Welch","year":"2023","journal-title":"Sci Adv"},{"key":"ppat.1014646.ref052","unstructured":"Turcinovic J. Transcriptomic analyses for a single-cycle, recombinant VSV platform Nipah vaccine cross-protects against Hendra virus in nonhuman primates. 2026."}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1014646","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1014646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:39:05Z","timestamp":1790703545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1014646"}},"subtitle":[],"editor":[{"given":"Benjamin G","family":"Hale","sequence":"first","affiliation":[{"name":"University of Zurich: Universitat Zurich","place":["SWITZERLAND"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1014646","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}